COEGIN — Coegin Pharma AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK95.78m
- SEK87.86m
- SEK0.08m
Annual cashflow statement for Coegin Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | — | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -25.8 | -35.2 | -28 | -23.8 | -20.5 |
| Non-Cash Items | 0.009 | 2.72 | 3.02 | 3.03 | 3.05 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.35 | -5.71 | 2.93 | -2.89 | 0.881 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -21.5 | -38.2 | -22 | -23.6 | -16.5 |
| Capital Expenditures | 0 | — | — | — | -0.124 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 12 | 0 | -0.048 | -0.056 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 12 | 0 | -0.048 | -0.18 |
| Financing Cash Flow Items | -2.56 | 4 | 0.925 | -3.66 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 29.3 | 4 | 23.8 | 37.9 | 5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9.01 | -21.8 | 1.73 | 14.1 | -11.8 |